GEN

Business Context and Reporting Period

This Form 10-Q covers Symantec Corporation (noting the metadata reference to Gen Digital Inc. is inconsistent with the filing text which identifies Symantec) for the quarterly period ended December 29, 2000. The company operates in the Internet security technology sector, providing virus protection, risk management, and remote management solutions. A defining event for this period was the acquisition of AXENT Technologies, Inc., effective December 18, 2000, for approximately $925 million.

Key Financial Metrics

Note: The Balance Sheet reports total cash, cash equivalents, and short-term investments of $715.9 million as of Dec 31, 2000. The Cash Flow statement reports ending cash and cash equivalents of $255.5 million, excluding short-term investments.

Material Changes vs. Prior Period

• Revenue Growth: Net revenues increased 9% year-over-year for the quarter and 8% for the nine-month period. Growth was driven by the Consumer and Small Business and Enterprise Solutions segments, partially offset by declines in e-Support and Other segments.
• Profitability Decline: Net income dropped significantly, down 84% for the quarter and 34% for the nine-month period compared to the prior year. This was primarily due to the absence of one-time gains from the sale of product lines (Visual Cafe and ACT!) in the prior year ($90 million gain in Q4 1999 vs. $5 million in Q4 2000).
• Acquisition Impact: The AXENT acquisition contributed $7.9 million in revenue for the quarter but resulted in a $22.3 million charge for acquired in-process research and development (IPR&D) and increased goodwill amortization.
• Foreign Currency: International revenues were negatively impacted by foreign currency fluctuations, resulting in a $15.3 million revenue decline for the quarter compared to prior year functional rates.

Guidance, Outlook, and Risks

Management Commentary: Management highlighted strong growth in anti-virus and internet security solutions. However, they noted that the integration of AXENT is complex and may disrupt operations. The company expects to continue investing in R&D to remain competitive.

Risks and Contingencies:

• Integration Risk: Difficulties in integrating AXENT's technology and personnel could adversely affect operations and stock price.
• Competition: Intense competition, particularly from Microsoft's inclusion of security features in Windows (e.g., Windows Millennium Edition), poses a threat to demand.
• Legal Proceedings: The company is involved in patent infringement claims and a class action regarding pre-version 4.0 Norton AntiVirus (resolved with no material impact). Management believes current litigation will not have a material adverse effect on financial condition.
• Market Volatility: Earnings and stock price are subject to significant fluctuations due to the timing of large enterprise site license sales and end-of-quarter buying patterns.

Investor Verification Checklist

• AXENT Integration: Verify the progress of integrating AXENT's technology and the realization of projected synergies versus the $925 million purchase price.
• Recurring Revenue Quality: Assess the sustainability of revenue growth excluding the one-time gains from divestitures present in the prior year.
• Goodwill Amortization: Monitor the impact of the $715 million goodwill recorded from the AXENT acquisition on future operating margins.
• Microsoft Competition: Evaluate the impact of new Windows operating system features on Symantec's core anti-virus product demand.
• Cash Position: Reconcile the difference between total liquid assets ($716M) and operating cash ($256M) to understand liquidity availability versus investment holdings.